600538 Stock Overview
Beihai Gofar Chuanshan Biological Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Beihai Gofar Chuanshan Biological Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.04 |
| 52 Week High | CN¥5.63 |
| 52 Week Low | CN¥2.90 |
| Beta | -0.43 |
| 11 Month Change | 18.59% |
| 3 Month Change | 65.79% |
| 1 Year Change | 8.62% |
| 33 Year Change | -31.34% |
| 5 Year Change | 13.00% |
| Change since IPO | -10.75% |
Recent News & Updates
Optimistic Investors Push Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Shares Up 32% But Growth Is Lacking
Oct 18
Investor Optimism Abounds Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) But Growth Is Lacking
Jul 12Recent updates
Optimistic Investors Push Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) Shares Up 32% But Growth Is Lacking
Oct 18Investor Optimism Abounds Beihai Gofar Chuanshan Biological Co., Ltd. (SHSE:600538) But Growth Is Lacking
Jul 12Beihai Gofar Chuanshan Biological Co., Ltd.'s (SHSE:600538) Shares Climb 34% But Its Business Is Yet to Catch Up
Mar 08Shareholder Returns
| 600538 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 3.3% | -0.9% | -2.1% |
| 1Y | 8.6% | -5.3% | 2.8% |
Return vs Industry: 600538 exceeded the CN Chemicals industry which returned -5.3% over the past year.
Return vs Market: 600538 exceeded the CN Market which returned 2.8% over the past year.
Price Volatility
| 600538 volatility | |
|---|---|
| 600538 Average Weekly Movement | 8.9% |
| Chemicals Industry Average Movement | 8.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600538 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600538's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 463 | Bin Pan Li | www.gofar.com.cn |
Beihai Gofar Chuanshan Biological Co., Ltd. engages in the production and distribution of pharmaceutical products in China. The company offers various medicines and medical devices; and produces and sells pearl eye drops, pearl powder, nacre powder, weiweining granules, compound Kumu Xiaoyan tablets, etc. under the Haibao brand.
Beihai Gofar Chuanshan Biological Co., Ltd. Fundamentals Summary
| 600538 fundamental statistics | |
|---|---|
| Market cap | CN¥2.64b |
| Earnings (TTM) | -CN¥87.46m |
| Revenue (TTM) | CN¥349.37m |
7.6x
P/S Ratio-30.2x
P/E RatioIs 600538 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600538 income statement (TTM) | |
|---|---|
| Revenue | CN¥349.37m |
| Cost of Revenue | CN¥263.25m |
| Gross Profit | CN¥86.12m |
| Other Expenses | CN¥173.58m |
| Earnings | -CN¥87.46m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 24.65% |
| Net Profit Margin | -25.03% |
| Debt/Equity Ratio | 0.4% |
How did 600538 perform over the long term?
See historical performance and comparison